Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990-1994/1995). Results of the JEVIN trial

Journal of Diabetes and its Complications

Volumn 20, Issue 5, 2006, Pages 273-279

  Schiel, Ralf ^a,b   Müller, Ulrich A ^b   Beltschikow, Wadim ^a   Stein, Günter ^b  

^a Inselklinik Heringsdorf GmbH   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Blocker; ACE inhibitor; Angiotensin II receptor blocker; Arterial hypertension; Diabetes mellitus; HbA1c; Insulin

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; FEMALE; FOLLOW UP; GERMANY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT CARE PLANNING; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE;

EID: 33748626792     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2005.07.011     Document Type: Article

References (30)

1. Agarwal R. Treatment of hypertension in patients with diabetes: Lessons from recent trials. Cardiology in Review 9 (2001) 36-44
2. Bobrie G., Chatellier G., Genes N., Clerson P., Vaur L., Vaisse B., Menard J., and Mallion J.M. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. Journal of the American Medical Association 291 (2004) 1342-1349
3. Burt V.L., Cutler J.A., Higgins M., Horan M.J., Labarthe D., Whelton P., Brown C., and Roccella E.J. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960-91. Hypertension 26 (1995) 60-69
4. Burt L.V., Whelton P., Roccella E.J., Brown C., Cutler J.A., Higgins M., Horan M.J., and Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25 (1995) 305-313
5. Colhoun H.M., Dong W., Barakat M.T., Mather H.M., and Poulter N.R. The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: A population-based analysis from the health surveys for England 1991-1994. Diabetic Medicine 16 (1999) 35-40
6. Collado-Mesa F., Colhoun H.M., Stevens L.K., Boavida J., Ferriss J.B., Karamanos B., Kempler P., Michel G., Roglic G., Fuller J.H., and the EURODIAB IDDM Complications Study Group. Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: The EURODIAB IDDM Complications Study. Diabetic Medicine 16 (1999) 41-48
7. Early Treatment Diabetic Retinopathy Study Group. Ophthalmology 98 Suppl. 5 (1991)
8. European Diabetes Policy Group 1998. A desktop guide to type 1 (insulin-dependent) diabetes mellitus. Diabetic Medicine 16 (1999) 253-266
9. European Diabetes Policy Group 1998-1999. International Diabetes Federation, European region: a desktop guide to type 2 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 107 (1999) 390-420
10. European IDDM Policy Group. Consensus guidelines for the management of insulin dependent (type 1) diabetes. Diabetic Medicine 10 (1993) 990-1005
11. Graves J.W., and Sheps S.G. Does evidence-based medicine should suggest that physicians should not be measuring blood pressure in the hypertensive patients?. American Journal of Hypertension 17 (2004) 354-360
12. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Journal of Hypertension 17 (1999) 151-183
13. Kaplan N.M. Management of hypertension in patients with type 2 diabetes mellitus: Guidelines based on current evidence. Annals of Internal Medicine 135 (2001) 1079-1083
14. Liebl A., Neiß A., Spannheimer A., Reitberger T., Wagner T., and Görtz A. Kosten des Typ-2-Diabetes in Deutschland. Ergebnisse der CODE-2-Studie. Deutsche Medizinische Wochenschrift 126 (2001) 585-589
15. Mühlhauser I., Overmann H., Bender R., Jörgens V., and Berger M. Predictors of mortality and end-stage diabetic complications in patients with type 1 diabetes mellitus on intensified insulin therapy. Diabetic Medicine 17 (2000) 727-734
16. Müller U.A., Femerling M., Reinauer K.M., Risse A., Voss M., Jörgens V., Berger M., Mühlhauser I., and for the ASD. Intensified treatment and education of type-1 diabetes mellitus as clinical routine: A nation-wide quality-circle experience in Germany. Diabetes Care 22 (1999) B29-B34
17. Ritz E. Albuminuria and vascular damage - the vicious twins. New England Journal of Medicine 348 (2003) 2349-2352
18. Rossing P., Hougaard P., Borch-Johnsen K., and Parving H.H. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. British Medical Journal 313 (1996) 779-784
19. Sawicki P.T., and for the Diabetes Treatment and Teaching Programmes Working Group. Stabilization of glomerular filtration rate over 2 years in patients with diabetic nephropathy under intensified therapy regimes. Nephrology, Dialysis, Transplantation 12 (1997) 1890-1899
20. Sawicki P.T., Bender R., Berger M., and Mühlhauser I. Non-linear effects of blood pressure and glycosylated haemoglobin on progression of diabetic nephropathy. Journal International de Médecine 247 (2000) 131-138
21. Schiel R., Bocklitz G., Braun A., Leppert K., Stein G., and Müller U.A. Cognitive function and quality of diabetes care in patients with type-2-diabetes mellitus in general practitioner practice. European Journal of Medical Research 8 (2003) 419-427
22. Schiel R., Franke S., Appel T., Voigt U., Ross I.S., Kientsch-Engel R., Stein G., and Müller U.A. Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN). Journal of Diabetes and its Complications 17 (2003) 90-97
23. Schiel R., Müller U.A., Sprott H., Schmelzer A., Mertes B., Hunger-Dathe W., and Ross I.S. The JEVIN-trial: a population-based survey on the quality of diabetes care in Germany - 1994/95 compared to 1989/90. Diabetologia 40 (1997) 1350-1357
24. Snow V., Weiss K.B., Mottur-Pilson C., and for the clinical efficacy assessment subcommittee of the American College of Physicians. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Annals of Internal Medicine 138 (2003) 587-592
25. Soedamah-Muthu S.S., Colhoun H.M., Abrahamian H., Chan N.N., Mangili R., Reboldi G.P., Fuller J.H., and the EURODIAB Prospective Complications Study Group. Trends in hypertension management in type I diabetes across Europe, 1989/1990-1997/1999. Diabetologia 45 (2002) 1362-1371
26. Stein G., Fünfstück R., and Schiel R. Diabetes mellitus and dialysis. Minerva Urologica e Nefrologica 56 (2004) 289-303
27. The Hypertension in Diabetes Study Group. Hypertension in diabetes study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. Journal of Hypertension 11 (1993) 319-325
28. The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Archives of Internal Medicine 157 (1997) 2413-2446
29. Wolf G., and Ritz E. Diabetic nephropathy in type 2 diabetes prevention and patient management. Journal of American Society of Nephrology 14 (2003) 1396-1405
30. Young M.J., Boulton A.J.M., Macleod A.F., Williams D.R.R., and Sonksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36 (1993) 150-154